The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Antidotes Market Research Report 2025

Global Antidotes Market Research Report 2025

Publishing Date : Mar, 2025

License Type :
 

Report Code : 1904135

No of Pages : 83

Synopsis

Antidote is agent that counters the effects of poison or over dosage by another drug. It helps in neutralizing the dangerous effects of a poison in body and has scientific approaches that have been taken to assess the therapeutic value of antidotes.

The global Antidotes market was valued at US$ 8408 million in 2023 and is anticipated to reach US$ 10600 million by 2030, witnessing a CAGR of 3.3% during the forecast period 2024-2030.

Global Antidote key players include Roche, Pfizer, Bayer, etc. Global top three manufacturers hold a share about 15%.
North America is the largest market, with a share about 35%, followed by Europe and China, both have a share about 50 percent.

In terms of product, Chemical Antidotes is the largest segment, with a share about 45%. And in terms of application, the largest application is Pesticide Poisoning, followed by Heavy Metal Poisoning.

This report aims to provide a comprehensive presentation of the global market for Antidotes, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Antidotes.

Report Scope

The Antidotes market size, estimations, and forecasts are provided in terms of sales volume (K MT) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Antidotes market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Antidotes manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

  • Baxter
  • Fresenius Kabi
  • Sandoz
  • Roche
  • Mylan
  • Pfizer
  • Teva
  • Glaxosmithkline
  • Merck

Segment by Type

  • Injection
  • Oral

Segment by Application

  • Hospital
  • Clinic

Consumption by Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Netherlands)
  • Asia-Pacific (China, Japan, South Korea, China Taiwan, Southeast Asia, India)
  • Latin America, Middle East & Africa (Latin America, Mexico, Brazil, Turkey)

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Antidotes manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Antidotes in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

Index

1 Antidotes Market Overview
1.1 Product Overview and Scope of Antidotes
1.2 Antidotes Segment by Type
1.2.1 Global Antidotes Market Value Comparison by Type (2024-2030)
1.2.2 Injection
1.2.3 Oral
1.3 Antidotes Segment by Application
1.3.1 Global Antidotes Market Value by Application: (2024-2030)
1.3.2 Hospital
1.3.3 Clinic
1.4 Global Antidotes Market Size Estimates and Forecasts
1.4.1 Global Antidotes Revenue 2019-2030
1.4.2 Global Antidotes Sales 2019-2030
1.4.3 Global Antidotes Market Average Price (2019-2030)
1.5 Assumptions and Limitations
2 Antidotes Market Competition by Manufacturers
2.1 Global Antidotes Sales Market Share by Manufacturers (2019-2024)
2.2 Global Antidotes Revenue Market Share by Manufacturers (2019-2024)
2.3 Global Antidotes Average Price by Manufacturers (2019-2024)
2.4 Global Antidotes Industry Ranking 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Antidotes, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Antidotes, Product Type & Application
2.7 Antidotes Market Competitive Situation and Trends
2.7.1 Antidotes Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Antidotes Players Market Share by Revenue
2.7.3 Global Antidotes Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Antidotes Retrospective Market Scenario by Region
3.1 Global Antidotes Market Size by Region: 2019 Versus 2023 Versus 2030
3.2 Global Antidotes Global Antidotes Sales by Region: 2019-2030
3.2.1 Global Antidotes Sales by Region: 2019-2024
3.2.2 Global Antidotes Sales by Region: 2025-2030
3.3 Global Antidotes Global Antidotes Revenue by Region: 2019-2030
3.3.1 Global Antidotes Revenue by Region: 2019-2024
3.3.2 Global Antidotes Revenue by Region: 2025-2030
3.4 North America Antidotes Market Facts & Figures by Country
3.4.1 North America Antidotes Market Size by Country: 2019 VS 2023 VS 2030
3.4.2 North America Antidotes Sales by Country (2019-2030)
3.4.3 North America Antidotes Revenue by Country (2019-2030)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Antidotes Market Facts & Figures by Country
3.5.1 Europe Antidotes Market Size by Country: 2019 VS 2023 VS 2030
3.5.2 Europe Antidotes Sales by Country (2019-2030)
3.5.3 Europe Antidotes Revenue by Country (2019-2030)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Antidotes Market Facts & Figures by Country
3.6.1 Asia Pacific Antidotes Market Size by Country: 2019 VS 2023 VS 2030
3.6.2 Asia Pacific Antidotes Sales by Country (2019-2030)
3.6.3 Asia Pacific Antidotes Revenue by Country (2019-2030)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Antidotes Market Facts & Figures by Country
3.7.1 Latin America Antidotes Market Size by Country: 2019 VS 2023 VS 2030
3.7.2 Latin America Antidotes Sales by Country (2019-2030)
3.7.3 Latin America Antidotes Revenue by Country (2019-2030)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Antidotes Market Facts & Figures by Country
3.8.1 Middle East and Africa Antidotes Market Size by Country: 2019 VS 2023 VS 2030
3.8.2 Middle East and Africa Antidotes Sales by Country (2019-2030)
3.8.3 Middle East and Africa Antidotes Revenue by Country (2019-2030)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Antidotes Sales by Type (2019-2030)
4.1.1 Global Antidotes Sales by Type (2019-2024)
4.1.2 Global Antidotes Sales by Type (2025-2030)
4.1.3 Global Antidotes Sales Market Share by Type (2019-2030)
4.2 Global Antidotes Revenue by Type (2019-2030)
4.2.1 Global Antidotes Revenue by Type (2019-2024)
4.2.2 Global Antidotes Revenue by Type (2025-2030)
4.2.3 Global Antidotes Revenue Market Share by Type (2019-2030)
4.3 Global Antidotes Price by Type (2019-2030)
5 Segment by Application
5.1 Global Antidotes Sales by Application (2019-2030)
5.1.1 Global Antidotes Sales by Application (2019-2024)
5.1.2 Global Antidotes Sales by Application (2025-2030)
5.1.3 Global Antidotes Sales Market Share by Application (2019-2030)
5.2 Global Antidotes Revenue by Application (2019-2030)
5.2.1 Global Antidotes Revenue by Application (2019-2024)
5.2.2 Global Antidotes Revenue by Application (2025-2030)
5.2.3 Global Antidotes Revenue Market Share by Application (2019-2030)
5.3 Global Antidotes Price by Application (2019-2030)
6 Key Companies Profiled
6.1 Baxter
6.1.1 Baxter Corporation Information
6.1.2 Baxter Description and Business Overview
6.1.3 Baxter Antidotes Sales, Revenue and Gross Margin (2019-2024)
6.1.4 Baxter Antidotes Product Portfolio
6.1.5 Baxter Recent Developments/Updates
6.2 Fresenius Kabi
6.2.1 Fresenius Kabi Corporation Information
6.2.2 Fresenius Kabi Description and Business Overview
6.2.3 Fresenius Kabi Antidotes Sales, Revenue and Gross Margin (2019-2024)
6.2.4 Fresenius Kabi Antidotes Product Portfolio
6.2.5 Fresenius Kabi Recent Developments/Updates
6.3 Sandoz
6.3.1 Sandoz Corporation Information
6.3.2 Sandoz Description and Business Overview
6.3.3 Sandoz Antidotes Sales, Revenue and Gross Margin (2019-2024)
6.3.4 Sandoz Antidotes Product Portfolio
6.3.5 Sandoz Recent Developments/Updates
6.4 Roche
6.4.1 Roche Corporation Information
6.4.2 Roche Description and Business Overview
6.4.3 Roche Antidotes Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Roche Antidotes Product Portfolio
6.4.5 Roche Recent Developments/Updates
6.5 Mylan
6.5.1 Mylan Corporation Information
6.5.2 Mylan Description and Business Overview
6.5.3 Mylan Antidotes Sales, Revenue and Gross Margin (2019-2024)
6.5.4 Mylan Antidotes Product Portfolio
6.5.5 Mylan Recent Developments/Updates
6.6 Pfizer
6.6.1 Pfizer Corporation Information
6.6.2 Pfizer Description and Business Overview
6.6.3 Pfizer Antidotes Sales, Revenue and Gross Margin (2019-2024)
6.6.4 Pfizer Antidotes Product Portfolio
6.6.5 Pfizer Recent Developments/Updates
6.7 Teva
6.6.1 Teva Corporation Information
6.6.2 Teva Description and Business Overview
6.6.3 Teva Antidotes Sales, Revenue and Gross Margin (2019-2024)
6.4.4 Teva Antidotes Product Portfolio
6.7.5 Teva Recent Developments/Updates
6.8 Glaxosmithkline
6.8.1 Glaxosmithkline Corporation Information
6.8.2 Glaxosmithkline Description and Business Overview
6.8.3 Glaxosmithkline Antidotes Sales, Revenue and Gross Margin (2019-2024)
6.8.4 Glaxosmithkline Antidotes Product Portfolio
6.8.5 Glaxosmithkline Recent Developments/Updates
6.9 Merck
6.9.1 Merck Corporation Information
6.9.2 Merck Description and Business Overview
6.9.3 Merck Antidotes Sales, Revenue and Gross Margin (2019-2024)
6.9.4 Merck Antidotes Product Portfolio
6.9.5 Merck Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Antidotes Industry Chain Analysis
7.2 Antidotes Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Antidotes Production Mode & Process
7.4 Antidotes Sales and Marketing
7.4.1 Antidotes Sales Channels
7.4.2 Antidotes Distributors
7.5 Antidotes Customers
8 Antidotes Market Dynamics
8.1 Antidotes Industry Trends
8.2 Antidotes Market Drivers
8.3 Antidotes Market Challenges
8.4 Antidotes Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

Published By : QY Research

Why ‘The Market Reports’